Skip to main content
Clinical Trials/JPRN-C000000454
JPRN-C000000454Completed未知

A study on preventive effect of cilostazol against deterioration of symptoms in acute stage of lacunar infarctions - A study on efficacy for cilostazol for acute stage of lacunar infarctions

Department of Neurology,Iwate Medical University0 sites60 target enrollmentStarted: August 1, 2006Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patients with active bleeding or bleeding tendency chronic heart falure peptic ulcer anemia leukocytopenia thrombocytopenia liver dysfunction renal dysfunction neoplastic disorders allergy to aspirin or cilostazol asthma caused by aspirin patients taking antiplatelet drugs, anticoagulants or NSAIDS

Investigators

Sponsor
Department of Neurology,Iwate Medical University

Similar Trials